Dynavax to Present at Upcoming Investor Conferences
Get Alerts DVAX Hot Sheet
Join SI Premium – FREE
William Blair 43rd Annual Growth Stock Conference onTuesday, June 6 at9:20 a.m. CT - Goldman Sachs 44th Annual Global Healthcare Conference on
Monday, June 12 at11:20 a.m. PT
The presentations will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.
About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the
For Investors/Media:
[email protected]
917-754-0207
[email protected]
510-665-7264
View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-upcoming-investor-conferences-301837611.html
SOURCE Dynavax Technologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin EDen Rich (BITBEDR) Is Now Available for Trading on LBank Exchange
- Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
- Lassila & Tikanoja plc: Interim Report 1 January–31 March 2024
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
William Blair, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!